IRAK1 and chronic myelogenous leukemia, BCR-ABL1 positive: However, because PD-L1 blockade was not effective at eliminating CML LSCs in the absence of T cell immunity, the proapoptotic function of the IRAK1/4 inhibitor is independent of the attenuation of PD-L1.